Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Antioxidative defense mechanisms controlled by Nrf2: state-of-the-art and clinical perspectives in neurodegenerative diseases.
How do corticosteroids influence myelin genesis in the central nervous system?
Extra-hippocampal subcortical limbic involvement predicts episodic recall performance in multiple sclerosis.
Cognitive impairment, health-related quality of life and vocational status at early stages of multiple sclerosis: a 7-year longitudinal study.
Oligodendrocyte N-Methyl-D-aspartate Receptor Signaling: Insights into Its Functions.
The complement system contributes to the pathology of experimental autoimmune encephalomyelitis by triggering demyelination and modifying the antigen-specific T and B cell response.
Demyelinating Disease following Anti-TNFa Treatment: A Causal or Coincidental Association? Report of Four Cases and Review of the Literature.
Cerebral venous thrombosis in a patient with clinically isolated spinal cord syndrome.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) in humans with multiple sclerosis.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
The conceptualization and development of a patient-reported neurogenic bladder symptom score.
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study.
MS Prevalence and Patients' Characteristics in the District of Braga, Portugal.
Telerehabilitation for persons with multiple sclerosis.
Inhibition of System Xc- Transporter Attenuates Autoimmune Inflammatory Demyelination.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis.
Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
Modulation of Immune response by Ultra-violet light in HLA class-II transgenic mice.
Prevalence of Classic and Non-Classic Antiphospholipid Antibodies in Multiple Sclerosis.
Fingolimod (FTY720-P) Does Not Stabilize the Blood-Brain Barrier under Inflammatory Conditions in an in Vitro Model.
Postural Motor Learning Deficits in People With MS in Spatial but Not Temporal Control of Center of Mass.
Use of Cannabinoids for Spasticity and Pain Management in MS.
Neuroinflammation preceding and accompanying primary central nervous system lymphoma: case study and literature review.

Pages